We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Innovative Technique Produces More Reliable Pluripotent Stem Cells

By LabMedica International staff writers
Posted on 01 Oct 2014
A recent paper described a more reliable way to induce the formation of pluripotent stem cells (iPSCs) from adult cells in a mouse model.

Reliable high-quality iPSCs are needed for the development of therapeutic applications. More...
Induced pluripotent stem cells are commonly generated by transduction of the "OSKM" genes into cells for the production of the reprogramming factors Oct4 (octamer-binding transcription factor 4), Sox2 (sex determining region Y)-box 2), Klf4 (Krueppel-like factor 4), and Myc (v-myc myelocytomatosis viral oncogene homolog protein). Although such iPSCs are pluripotent, they frequently exhibit high variation in terms of quality, as measured in mice by chimera contribution and tetraploid complementation.

Investigators at the Hebrew University of Jerusalem (Israel) used bioinformatic analysis to design a new formulation of transducer genes that generated high-quality iPSCs more efficiently than other combinations of factors including OSKM. The new cocktail of reprogramming factors (SNEL) included Sall4 (Sal-like protein 4), Nanog (Nanog homeobox), Esrrb (Estrogen-related receptor beta), and Lin28 (Lin-28 homolog A).

The new SNEL cocktail created fewer iPSC colonies than the traditional OSKM approach, but approximately 80% of those produced passed the most stringent pluripotency tests. This is preferable to the OSKM method, which produces a large number of colonies, but the majority of which fail the pluripotency tests.

First author Dr. Yossi Buganim, a postdoctoral researcher in developmental biology at the Hebrew University of Jerusalem, said, "SNEL may reprogram cells better than OSKM because it does not rely on the master regulators Oct4 and Sox2, which might activate part of the adult cell genome. This research demonstrates the effectiveness of bioinformatics tools in producing high quality iPSCs."

Related Links:
Hebrew University of Jerusalem



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
New
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.